Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer

Journal of the Endocrine Society(2023)10.1210/jendso/bvad117Source: DataRank Database

Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer is a research paper published in Journal of the Endocrine Society (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

cellosaurus rrid doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.76)OA: goldTopics (21)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Hillary Stires,Shaymaa Bahnassy ORCID,Sonali Persaud,Yanira Guerra,Suman Ranjit ORCID

Live enrichment

PubMed:37766843 PMC:PMC10521904 OpenAlex:https://openalex.org/W4386767490

NCI NIH HHS

Grant: T32 CA009686

NCI NIH HHS

Grant: P30 CA051008

National Institutes of Health

Grant: 3P30CA051008-16S1

CANCER CENTER SUPPORT GRANT

National Institutes of Health

Grant: 3T32CA009686-05S1

TRAINING GRANT IN TUMOR BIOLOGY

Georgetown Undergraduate Research Opportunities Program

NCI

NIH

Department of Defense

FWCI

1.76

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

goldLicense: cc-by

journalhttps://academic.oup.com/jes/advance-article-pdf/doi/10.1210/jendso/bvad117/51606059/bvad117.pdf

publisherhttps://academic.oup.com/jes/advance-article-pdf/doi/10.1210/jendso/bvad117/51606059/bvad117.pdf

journalhttps://doi.org/10.1210/jendso/bvad117

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37766843

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10521904

Fields of Study

Amyotrophic Lateral Sclerosis ResearchCancer, Stress, Anesthesia, and Immune ResponseWnt/β-catenin signaling in development and cancer0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

RiluzoleEndocrine systemOncologyMedicineBreast cancerInternal medicineCancer researchCancerHormoneDiseaseAmyotrophic lateral sclerosisEstrogen receptorFulvestrantInvasive Lobular Breast CancerResearch Article

Sustainable Development Goals

SDG 0: Good health and well-being

Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer

FAIR Checklist

Authors (15)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)